Companies / changshan-biochemical-pharmaceutical

Changshan Biochemical Pharmaceutical

ChinaTechnology & Electronics

Overview

Hebei Changshan Biochemical Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, marketing, and sale of drugs for cardiovascular, cerebrovascular, diabetes, and cancer in China and internationally. It offers heparin sodium, calcium, and lithium, as well as heparinoid, LMW heparins, and sodium hyaluronate; dalteparin sodium, enoxaparin sodium, nadroparin calcium, and heparin sodium injections, as well as sildenafil citrate tablet; and albenat

Employees1194
Market Cap$36.5B
Revenue$872.5M
Listed OnShenzhen Stock Exchange
Ticker300255
CEOMr. Xiaodong Gao
HeadquartersShijiazhuang

Website

https://www.hbcsbio.com